Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl )piperazine

Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl )piperazine

US Patent 5063220 · Granted Nov 5, 1991

Estimated economic value: $28,271,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutical composition containing apomorphine as active ingredient2023
Method of treating osteoporosis comprising administration of PTHrP analog2023
Therapeutical composition containing apomorphine as active ingredient2021
Method of drug delivery for bone anabolic protein2014
Stable composition comprising a PTHrP analogue2012
Method of treating osteoporosis comprising administration of PTHrP analog2010
Long acting calcium channel blocker composition1993
Long acting calcium channel blocker composition1993
Long acting nicardipine hydrochloride formulation1993
Long acting nicardipine hydrochloride formulation1993
Nicardipine pharmaceutical composition for parenteral administration1992
Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-i1990